Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Review hepatobiliary radiopharmaceuticals with this Tc-99m Hepatobiliary IDA Agents Board Review Chart, designed for nuclear medicine technology students preparing for board exams, clinical rotations, and hepatobiliary imaging review.
This digital study chart compares the major Tc-99m IDA agents, including lidofenin (HIDA), disofenin (DISIDA), and mebrofenin (BRIDA/Choletec). Each agent is organized by typical dose, clearance half-time, hepatic uptake, renal excretion, bilirubin tolerance, and high-yield board exam characteristics.
The chart also includes a visual review of hepatobiliary physiology, showing how IDA agents bind albumin, travel to the liver, enter hepatocytes, and are excreted into the biliary system. Key board pearls highlight why mebrofenin is often preferred in patients with elevated bilirubin and how hepatic extraction improves across the IDA agents.
Perfect for:
Nuclear medicine board exam review
HIDA scan study
Hepatobiliary radiopharmaceutical review
Clinical rotation preparation
Radiopharmacy and physiology review
Visual learners who prefer organized study charts
This is a digital educational study aid intended for review purposes only. Always verify information with your nuclear medicine program materials, institutional protocols, package inserts, and current references.
Review hepatobiliary radiopharmaceuticals with this Tc-99m Hepatobiliary IDA Agents Board Review Chart, designed for nuclear medicine technology students preparing for board exams, clinical rotations, and hepatobiliary imaging review.
This digital study chart compares the major Tc-99m IDA agents, including lidofenin (HIDA), disofenin (DISIDA), and mebrofenin (BRIDA/Choletec). Each agent is organized by typical dose, clearance half-time, hepatic uptake, renal excretion, bilirubin tolerance, and high-yield board exam characteristics.
The chart also includes a visual review of hepatobiliary physiology, showing how IDA agents bind albumin, travel to the liver, enter hepatocytes, and are excreted into the biliary system. Key board pearls highlight why mebrofenin is often preferred in patients with elevated bilirubin and how hepatic extraction improves across the IDA agents.
Perfect for:
Nuclear medicine board exam review
HIDA scan study
Hepatobiliary radiopharmaceutical review
Clinical rotation preparation
Radiopharmacy and physiology review
Visual learners who prefer organized study charts
This is a digital educational study aid intended for review purposes only. Always verify information with your nuclear medicine program materials, institutional protocols, package inserts, and current references.